BCL2 and thymoma: Furthermore, copy number gains of MCL1, another member of the BCL2 family gene, have been observed in 51% of TETs, predominantly in aggressive histological subtypes (83% in type B2/B3 thymomas, 70% in type B3 thymomas and 57% in thymic carcinomas).